Tg Therapeutics Inc (TGTX)

Deferred Revenue

$16.83M

Quarterly · Period ending: · USD

TGTX logo

TGTX Deferred Revenue

Latest reported$16.83M
TGTX Quarterly Deferred Revenue ($0.00 → $16.83M)
High-resolution chart · PNG

TGTX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
16,825,000
17,190,000
21,234,000
26,399,000
23,911,000
17,079,000
11,414,000
9,093,000
3,373,000
3,373,000
152,000
6,903,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
800,000
-31,498,000
854,000
152,000
152,000
152,000
152,000
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
152,381
0
0
0
-438,018,000
47,223
160,061
565,879
480,890
415,256
351,574
290,439
257,968
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-902,328
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.